Aytu Bioscience Inc Stock OTC Bulletin Board
Stocks
AYTU
US0547542052
Pharmaceuticals
|
End-of-day quote
OTC Bulletin Board
|
||
| - USD | - |
|
| 09-22 | Aytu BioPharma, Inc., Q4 2026 Earnings Call, Sep 22, 2026 | |
| 09-22 | Aytu BioPharma, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended June 30, 2026 | CI |
| Market Cap | 24.78M 21.79M 20.61M 18.69M 35.1M 2.38B 35.3M 247M 95.28M 1.21B 93.02M 91.01M 3.9B | P/E 2027 * |
-2.65x | P/E 2028 * | 6.81x |
|---|---|---|---|---|---|
| Enterprise Value | 24.78M 21.79M 20.61M 18.69M 35.1M 2.38B 35.3M 247M 95.28M 1.21B 93.02M 91.01M 3.9B | EV / Sales 2027 * |
0.37x | EV / Sales 2028 * | 0.27x |
| Free-Float |
91.84% | Yield 2027 * |
-
| Yield 2028 * | - |
Last Transcript: Aytu Bioscience Inc
| Manager | Title | Age | Since |
|---|---|---|---|
Jarrett Disbrow
COO | Chief Operating Officer | 51 | 2015-04-15 |
Joshua Disbrow
CEO | Chief Executive Officer | 51 | 2015-04-15 |
Ryan Selhorn
DFI | Director of Finance/CFO | 44 | 2024-11-10 |
| Director | Title | Age | Since |
|---|---|---|---|
Joshua Disbrow
CHM | Chairman | 51 | 2015-04-15 |
Carl Dockery
BRD | Director/Board Member | 63 | 2016-04-12 |
John Donofrio
CHM | Chairman | 59 | 2024-11-05 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.15% | +14.13% | +679.19% | +96.84% | 79.4B | ||
| -4.54% | -5.91% | +33.93% | -10.01% | 78.69B | ||
| +2.80% | +3.60% | -6.34% | -27.82% | 59.52B | ||
| -0.89% | +2.11% | +7.92% | +170.43% | 46.58B | ||
| +2.49% | +0.14% | -8.95% | +33.71% | 46.53B | ||
| +0.50% | +4.12% | +64.67% | -11.53% | 33.63B | ||
| +0.68% | +0.17% | +48.84% | +113.04% | 25.11B | ||
| -3.56% | -0.47% | +3.11% | +135.37% | 22.13B | ||
| +0.73% | -0.95% | +57.27% | +97.04% | 15.31B | ||
| Average | -0.25% | +4.30% | +97.74% | +66.34% | 45.21B | |
| Weighted average by Cap. | -0.45% | +6.71% | +148.74% | +53.29% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 67.86M 59.69M 56.44M 51.19M 96.14M 6.51B 96.7M 676M 261M 3.32B 255M 249M 10.68B | 92.36M 81.23M 76.81M 69.67M 131M 8.87B 132M 920M 355M 4.52B 347M 339M 14.54B |
| Net income | -11.8M -10.38M -9.81M -8.9M -16.72M -1.13B -16.81M -117M -45.38M -578M -44.3M -43.34M -1.86B | 4.7M 4.13M 3.91M 3.55M 6.66M 451M 6.7M 46.81M 18.08M 230M 17.65M 17.27M 740M |
| Net Debt | - | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- AYTU Stock
- AYTU Stock
Select your edition
All financial news and data tailored to specific country editions
















